NSCLC NON-SMALL CELL LUNG CANCER
Clinical trials for NSCLC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NSCLC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NSCLC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI designs custom vaccines to fight lung cancer
Disease control ENROLLING_BY_INVITATIONThis early-stage study is testing a personalized vaccine, Microlyvaq™, for people with advanced non-small cell lung cancer (NSCLC). The vaccine is custom-made for each patient using AI to analyze their specific tumor. It is given alongside standard chemotherapy and immunotherapy …
Matched conditions: NSCLC NON-SMALL CELL LUNG CANCER
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New cancer drug trial tests immune system 'Decoy' to fight advanced tumors
Disease control OngoingThis early-stage study is testing a new immunotherapy drug called DECOY20, both alone and combined with another cancer drug (tislelizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses, check for s…
Matched conditions: NSCLC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Indaptus Therapeutics, Inc • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC